When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.
Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships
|July 11, 2012||Verastem Acquires Clinical-Stage FAK Inhibitor from Pfizer|
|May 1, 2012||Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™|
|April 23, 2012||Quark Pharmaceuticals Announces Phase 2a Study of PF-04523655 (PF-655)|
|March 12, 2012||Biocon And Pfizer Conclude Commercialization Agreement|
|February 27, 2012||Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company|
|February 17, 2012||Pfizer And Hisun Announce Progress On Potential Joint Venture|